Structural Formula (Myc03 0007 01)
Mycophenolate Mofetil Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-803
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 71288-803). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel – Mycophenolate Mofetil For Injection, Usp 500 mg Vial Label (Myc03 0007 02)
Principal Display Panel – Mycophenolate Mofetil For Injection, Usp 500 mg Carton (Myc03 0007 03)
Mycophenolate Mofetil for Injection is a non-pyrogenic and preservative-free sterile medication available in single-dose vials, each containing 500 mg (542 mg of mycophenolate mofet hydrochloride equivalent) of the drug, along with 25 mg of polysorbate 80 and 5 mg of anhydrous citric acid. Sodium hydroxide and/or hydrochloric acid is used to maintain pH levels. Reconstitution of the vials with 14 mL of 5% dextrose injection is mandatory before its infusion at a final concentration of 6 mg/mL. The medication must be discarded after four hours of reconstitution and dilution. There is no information available on dosage recommendations, and it is advised to read the accompanying insert for prescribing information. Mycophenolate Mofetil for Injection must be stored between 20° to 25°C; however, excursions are permitted between 15° and 30°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
